VS-505

· KDL Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VS-505, covering 2016-02-08 to 2016-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis [Phase 1, Phase 2]